Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis
Clinical trial NCT07035561 · COMPLETED
Trial details
- NCT number
- NCT07035561
- Sponsor
- Shereen Medhat Mohammed Elsayed Nassar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2025-01-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.